ON2 Assessing the Performance of Landmark Response Analysis to Improve Overall Survival Extrapolation in Nivolumab NSCLC Trials

Dec 1, 2020, 00:00
10.1016/j.jval.2020.08.062
https://www.valueinhealthjournal.com/article/S1098-3015(20)32318-4/fulltext
Title : ON2 Assessing the Performance of Landmark Response Analysis to Improve Overall Survival Extrapolation in Nivolumab NSCLC Trials
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)32318-4&doi=10.1016/j.jval.2020.08.062
First page :
Section Title :
Open access? : No
Section Order : 10039
Categories :
Tags :
Regions :
ViH Article Tags :